The grant will support research to find guidelines for the management of children with NF1, determine clinical and molecular risk factors for the development of NF1, and develop immunotherapies, according to an April 4 CHOP news release.
NF1 is a genetic disorder that can lead to skin changes, skeletal abnormalities and tumors. The disorder affects 1 in 3,000 people.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
